80
China Biotech Services Holdings Limited
8037.HK · HKSE
$0.63 +3.28% (+$0.02)
1M -5.26%
Market Cap $595.2M
P/E Ratio -
Div. Yield -
ROE 31.06%
Piotroski F-Score Weak
2/9Valuation
35 /100
Fair P/S 8.10x
P/B 3.11x
P/E N/A
Growth
0 /100
Declining Rev. growth 65.89%
Book val. growth 31.77%
EPS growth N/A
Profitability
1 /100
Weak Gross margin 10.51%
FCF margin 267.47%
Net margin 93.57%
Quality
1 /100
Poor ROIC 12.70%
Asset turnover 0.10x
ROE 31.06%
Debt
8 /100
High Debt/Equity 2.06x
Int. coverage -3.90x
Current ratio 0.23x
Stability
13 /100
Unstable Beta -0.66x
Profitable years 0
Rev. volatility 48.52%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 8037.HK
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Xiaolin Liu
Employees
135
Headquarters
Hong Kong